Literature DB >> 27488278

Weight loss among women and men in the ASPIRE-VA behavioral weight loss intervention trial.

Varsha Vimalananda1,2, Laura Damschroder3, Carol A Janney3, David Goodrich3, H Myra Kim4, Robert Holleman3, Leah Gillon3, Lesley Lutes5.   

Abstract

OBJECTIVE: Weight loss was examined among women and men veterans in a clinical trial comparing Aspiring for Lifelong Health (ASPIRE), a "small changes" weight loss program using either mixed-sex group-visit or telephone-based coaching, to MOVE!(®) , the usual mixed-sex group-based program.
METHODS: Linear mixed-effects models were used to calculate adjusted percent weight change at 12 months by sex and compare outcomes across arms within sex.
RESULTS: Analyses included 72 women (ASPIRE-Phone = 26; ASPIRE-Group = 26; MOVE! = 20) and 409 men (ASPIRE-Phone = 136; ASPIRE-Group = 134; MOVE! = 139). At 12 months, women displayed significant weight loss from baseline in ASPIRE-Group (-2.6%) and MOVE! (-2.7%), but not ASPIRE-Phone (+0.2%). Between-arm differences in weight change among women were: ASPIRE-Group versus ASPIRE-Phone, -2.8% (P = 0.15); MOVE! versus ASPIRE-Phone, -2.8% (P = 0.20); and ASPIRE-Group versus MOVE!, 0.0% (P = 1.0). At 12 months, men lost significant weight from baseline across arms (ASPIRE-Phone, -1.5%; ASPIRE-Group, -2.5%; MOVE!, -1.0%). Between-arm differences in weight change among men were: ASPIRE-Group versus ASPIRE-Phone, -0.9% (P = 0.23); MOVE! versus ASPIRE-Phone, +0.5% (P = 0.76); ASPIRE-Group versus MOVE!, -1.5% (P = 0.03).
CONCLUSIONS: Mixed-sex, group-based programs can result in weight loss for both women and men veterans.
© 2016 The Obesity Society.

Entities:  

Mesh:

Year:  2016        PMID: 27488278     DOI: 10.1002/oby.21574

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  8 in total

1.  Outcome by Gender in the Veterans Health Administration Motivating Overweight/Obese Veterans Everywhere Weight Management Program.

Authors:  Bryan C Batch; Karen Goldstein; William S Yancy; Linda L Sanders; Susanne Danus; Steven C Grambow; Hayden B Bosworth
Journal:  J Womens Health (Larchmt)       Date:  2017-07-21       Impact factor: 2.681

2.  Patient Characteristics Associated with Receipt of Prescription Weight-Management Medications Among Veterans Participating in MOVE!

Authors:  Dylan D Thomas; Molly E Waring; Omid Ameli; Joel I Reisman; Varsha G Vimalananda
Journal:  Obesity (Silver Spring)       Date:  2019-05-15       Impact factor: 5.002

Review 3.  Sex/Gender Differences in Obesity Prevalence, Comorbidities, and Treatment.

Authors:  Ashley J Cooper; Sapana R Gupta; Afaf F Moustafa; Ariana M Chao
Journal:  Curr Obes Rep       Date:  2021-10-02

4.  Continuous quality improvement at the frontline: One interdisciplinary clinical team's four-year journey after completing a virtual learning program.

Authors:  Claire H Robinson; Amy J Thompto; Elizabeth N Lima; Laura J Damschroder
Journal:  Learn Health Syst       Date:  2022-09-27

5.  Relationships Between Dietary Intake and Weight-Related Experiential Avoidance Following Behavioral Weight-Loss Treatment.

Authors:  Jennalee S Wooldridge; Brian H Blanco; Cara Dochat; Matthew S Herbert; Kathryn M Godfrey; Jennifer Salamat; Niloofar Afari
Journal:  Int J Behav Med       Date:  2021-04-17

6.  Women Veterans Experience with the VA MOVE! Weight Management Program.

Authors:  Bryan C Batch; Candace S Brown; Karen M Goldstein; Susanne Danus; Nina R Sperber; Hayden B Bosworth
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-03-04

Review 7.  Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR Outcomes Addendum.

Authors:  Laura J Damschroder; Caitlin M Reardon; Marilla A Opra Widerquist; Julie Lowery
Journal:  Implement Sci       Date:  2022-01-22       Impact factor: 7.327

8.  Internet-based platform for a low-calorie dietary intervention involving prepackaged food for weight loss in overweight and obese individuals in China: protocol for a randomised controlled trial.

Authors:  Xi Wang; Suyuan Wang; Chenghui Zhang; Lingyu Zhong; Lilach Lerman; Amir Lerman; Yanhong Guo; Yunhong Wu; Francisco Lopez-Jimenez
Journal:  BMJ Open       Date:  2022-01-21       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.